Taiwan Food and Drug Administration (FDA) is considering the use of 2’-fucosyllactose (2’-FL) fermented from two new microbial strains in all infant and toddler food products, including Foods for Special Medical Purposes (FSMPs).
Two of Nestlé Health Science China’s infant nutrition products for youngsters with cow’s milk allergies have obtained Food for Special Medical Purposes (FSMPs) status in the country.
